- 301. Threatened premature labor, antepartum
- [ ] (UMLS (ICD9CM) C0156714) =Disease or Syndrome
| - 351. Thymectacin
- (UMLS (NCI) C1135140) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
|
- 302. Three Affiliated Tribes of the Fort Berthold Reser
- (UMLS (HL7) C1554519) =Population Group =NativeEntityContiguous;
| - 352. thymectomy
- [surgical removal of the thymus gland. ( CSP )] (UMLS (CSP) C0040071) =Therapeutic or Preventive Procedure =Chest Surgery;
lymphatic tissue surgery |
- 303. three dimensional imaging/topography
- [images which show length, width and depth of the object; can be generated or simulated by assembling multiple tomographic images with the aid of a computer; topography is the physical or natural features of an object or entity and their structural relationships; for photographic 3-D images see HOLOGRAPHY. ( CSP )] (UMLS (CSP) C1171319) =Diagnostic Procedure =imaging/visualization/scanning;
| - 353. thymic aplasia
- [ ] (UMLS (CSP) C0685894) =Congenital Abnormality
|
- 304. three dimensional treatment planning
- [ ] (UMLS (CSP) C0598931) =Health Care Activity ;
| - 354. Thymic Capsule
- (UMLS (NCI) C0229945) =Body Part, Organ, or Organ Component
|
- 305. Three micron Giemsa stain
- [Stain, Three micron Giemsa ( HL7V3.0 )] (UMLS (HL7) C1293975) =Laboratory Procedure =ObservationMethod;
| - 355. Thymic Carcinoma
- [A diverse group of carcinomas of the thymus gland, previously known as thymoma type C (WHO-1999). It includes morphologic variants derived from purely epithelial cells, as well as from cells with neuroendocrine differentiation. ( NCI )] (UMLS (NCI) C1322286) Thymic Carcinoma (Excluding Well Differentiated Thymic Carcinoma);
Thymic Carcinoma Excluding Well Differentiated Thymic Carcinoma;
Thymoma Type C =Neoplastic Process |
- 306. Three Prime Repair Exonuclease 1 Gene
- [This gene plays a role in cellular DNA damage checkpoints. ( NCI )] (UMLS (NCI) C1336670) TREX1;
TREX1 Gene =Gene or Genome ;
| - 356. Thymic Cyst
- (UMLS (NCI) C0040072) =Acquired Abnormality
|
- 307. Three Prime Repair Exonuclease 2 Gene
- [This gene is involved in DNA repair and in the maintenance of DNA integrity. ( NCI )] (UMLS (NCI) C1336671) TREX2;
TREX2 Gene =Gene or Genome ;
| - 357. Thymic Dysplasia
- (UMLS (NCI) C1331541) =Disease or Syndrome
|
- 308. three times a day at institution-specified times
- [Three times a day at institution specified time ( HL7V3.0 )] (UMLS (HL7) C1610169) TID =Temporal Concept ;
=Repeat;
GTSAbbreviation | - 358. thymic hypoplasia
- [ ] (UMLS (CSP) C0685891) =Congenital Abnormality
|
- 309. Three times a week
- [Three times per week. ( NCI )] (UMLS (NCI) C0556987) =Temporal Concept
| - 359. Thymic Stromal Lymphopoietin
- [Widely expressed in heart, liver, testis, prostate, smooth muscle, keratinocytes, epithelia, and lung fibroblasts by human TSLP Gene (B Cell-Stimulating Cytokine Family), 159-aa 18-kDa hemopoietic cytokine Thymic Stromal Lymphopoietin contains a 28-aa signal sequence, 6 conserved cysteines, 2 N-glycosylation sites, and 7 basic C-terminal amino acids (KKRRKRK). TSLP signals through a heterodimeric TSLPR(CRLF2)/IL7R Alpha receptor. Like IL7, TSLP stimulates STAT5 phosphorylation. Dendritic cells (DC) and monocytes coexpress IL7R and TSLPR. TSLP induces release of T cell-attracting chemokines from monocytes, expression of cytokines and costimulatory molecules in DCs, enhances DC maturation, and induces T-cell proliferation. TSLP also inhibits apoptosis in some cells. (NCI) ( NCI )] (UMLS (NCI) C0762640) Thymic Stromal Lymphopoietin Protein TSLP;
TSLP;
=Amino Acid, Peptide, or Protein; Immunologic Factor |
- 310. THREONINE
- [alpha-amino beta-hydroxy butyric acid, a natural amino acid essential for optimal growth in infants and for nitrogen equilibrium in adults. ( CSP )] (UMLS (NCI) C0040005) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Amino Acids, Essential;
Amino Acids, Neutral;
hydroxyaminoacid;
primary aminoacid | - 360. Thymic Stromal Lymphopoietin Gene
- [This gene plays a regulatory role in the development of B lymphocytes. ( NCI )] (UMLS (NCI) C1336681) TSLP;
TSLP Gene =Gene or Genome ;
|
- 311. threonine deaminase
- [A pyridoxal-phosphate protein that catalyzes the deamination of THREONINE to 2-ketobutyrate and AMMONIA. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for ISOLEUCINE biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. This enzyme was formerly listed as EC 4.2.1.16. ( MSH )] (UMLS (CSP) C0040008) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 361. Thymic Undifferentiated Carcinoma
- [A rare primary thymic carcinoma, characterized by an undifferentiated solid tumor growth, without associated sarcomatoid features. — 2005 ( NCI )] (UMLS (NCI) C1336865) =Neoplastic Process
|
- 312. Threshold
- [The lowest limit at which something becomes detectable or relevant. ( NCI )] (UMLS (NCI) C0449864) =Functional Concept ;
| - 362. Thymic Vein
- (UMLS (NCI) C0226698) =Body Part, Organ, or Organ Component
|
- 313. Throat
- (UMLS (HL7) C1547926) =Intellectual Product =Specimen Source Codes;
| - 363. Thymidine Kinase 1, Soluble Gene
- [This gene is involved in the metabolism of nucleosides, nucleotides and nucleic acids in the cytosol. ( NCI )] (UMLS (NCI) C1420747) TK1;
TK1 Gene =Gene or Genome |
- 314. Throat
- (UMLS (HL7) C1550663) =Body Substance =SpecimenEntityType;
| - 364. Thymidine Kinase 2, Mitochondrial Gene
- [This gene plays a role in mitochondrial DNA synthesis in non-replicating cells. ( NCI )] (UMLS (NCI) C1420748) TK2;
TK2 Gene =Gene or Genome |
- 315. Throat
- (UMLS (NCI) C0230069) =Body Location or Region
| - 365. Thymidine Kinase Gene
- [The TK Gene encodes thymidine kinase, a transferase class pyrimidine salvage enzyme that catalyzes ATP-dependent phosphorylation of thymine deoxyribonucleoside. The TK gene and promoter are used widely in genetic research because of the easily selectable phenotype. ( NCI )] (UMLS (NCI) C1336633) TK Gene;
=Gene or Genome ;
|
- 316. Throat Cancer
- [Carcinoma, predominantly squamous cell, arising from epithelial cells of the larynx or pharynx. — 2004 ( NCI )] (UMLS (NCI) C0740339) Throat Carcinoma =Neoplastic Process ;
| - 366. thymidine monophosphate
- [a nucleotide, the 5'-phosphate of thymidine. ( CSP )] (UMLS (CSP) C0040079) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
=pyrimidine nucleotide;
|
- 317. Thrombectomy
- [Surgery performed with the purpose of removing a thrombus. ( NCI )] (UMLS (NCI) C0162578) =Therapeutic or Preventive Procedure ;
| - 367. thymidine triphosphate
- [ ] (UMLS (CSP) C0076582) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
|
- 318. Thrombin
- [Thrombin. Accelerates clotting. ( HL7V3.0 )] (UMLS (HL7) C1550090) =Intellectual Product ;
=MaterialEntityAdditive;
| - 368. thymidylate
- [ ] (UMLS (CSP) C0599538) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
|
- 319. Thrombin NIH; soybean trypsin inhibitor
- [Thrombin plus soybean trypsin inhibitor. For use in identifying fibrn degredation products. ( HL7V3.0 )] (UMLS (HL7) C1553432) =Intellectual Product =MaterialEntityAdditive;
| - 369. Thymidylate Synthase Gene
- [This gene is involved in DNA replication and repair. ( NCI )] (UMLS (NCI) C1366824) TYMS;
TYMS Gene;
=Gene or Genome ;
|
- 320. Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products)
- (UMLS (HL7) C1550068) =Biomedical or Dental Material; ;
=Additive/Preservative;
| - 370. Thymidylate Synthase Inhibitor
- [A family of drugs that block DNA synthesis and may prevent tumor cell growth. They are being studied as a treatment for cancer. ( NCI )] (UMLS (NCI) C1373008) thymidylate synthase inhibitors;
Thymidylate Synthetase Inhibitors =Pharmacologic Substance =antifolate;
|
- 321. thrombin receptor
- [cell surface proteins that specifically bind thrombin and trigger changes in the behavior of blood cells. ( CSP )] (UMLS (CSP) C0076552) =Amino Acid, Peptide, or Protein; Receptor ;
=membrane protein;
Cell Surface Receptor | - 371. thymine dimer
- [ ] (UMLS (CSP) C0040092) =Nucleic Acid, Nucleoside, or Nucleotide
|
- 322. Thrombin-Antithrombin Complex
- [A protease involved in clotting ( NCI )] (UMLS (NCI) C0052128) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 372. thymine riboside
- [ ] (UMLS (CSP) C0597582) =Nucleic Acid, Nucleoside, or Nucleotide
|
- 323. Thrombocidin 1
- (UMLS (NCI) C1455542) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 373. Thymitaq
- (UMLS (NCI) C0935948) =Organic Chemical; Pharmacologic Substance ;
|
- 324. Thrombocidin 2
- (UMLS (NCI) C1455541) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 374. Thymocyte
- [A cell that develops in the thymus, seemingly from a stem cell of bone marrow and of fetal liver, and is the precursor of the thymus-derived lymphocyte (T lymphocyte) that effects cell-mediated (delayed type) sensitivity. ( NCI )] (UMLS (NCI) C0814999) Thymocytes;
=Cell ;
|
- 325. Thrombocyte (platelet)
- (UMLS (HL7) C1547925) =Intellectual Product =Specimen Source Codes;
| - 375. Thymoglobulin
- (UMLS (NCI) C0730920) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 326. Thrombocyte (platelet)
- (UMLS (HL7) C1550664) =Body Substance =SpecimenEntityType;
| - 376. Thymol
- [A phenol obtained from thyme oil or other volatile oils. It is used as a stabilizer in pharmaceutic preparations. It has been used for its antiseptic, antibacterial, and antifungal actions, and was formerly used as a vermifuge. (Dorland, 28th ed) ( MSH )] (UMLS (HL7) C0040096) =Organic Chemical; Pharmacologic Substance ;
=terpene;
[DE109] ANTI-INFECTIVE, TOPICAL OTHER;
Inactive Ingredient Preparations;
Additive/Preservative =THYMOL IODIDE;
ABSORBINE JR LINIMENT;
ALCOHOL/BENZOIC ACID/EUCALYPTOL/ME SALICYLATE/THYMOL MOUTHWASH;
ALCOHOL/BENZOIC ACID/EUCALYPTOL/METHYL SALICYLATE/THYMOL LIQUID;
ALCOHOL/EUCALYPTOL/MENTHOL/ME SALICYLATE/THYMOL MOUTHWASH;
ALCOHOL/MENTHOL 2%/THYMOL GEL,TOP;
ALKALOL SOLUTION;
BFI PWDR,TOP;
COLD SORE LOTION;
EXTRA STRENGTH ABSORBINE JR LINIMENT;
FESTEX OINT,TOP;
GORDOBALM GEL,TOP;
GORDOMATIC CRYSTALS;
GORDOMATIC PWDR,TOP;
MASSENGILL DOUCHE LIQUID CONCENTRATE,VAG;
MASSENGILL DOUCHE POWDER,VAG;
Menthol 0.02 MG/MG Topical Gel;
THYMOL 4 % |
- 327. thrombocytopenia
- [decrease in the number of blood platelets. ( CSP )] (UMLS (NCI) C0040034) =Disease or Syndrome =Blood Platelet Disorders;
=Aldrich syndrome;
Purpura, Thrombocytopenic;
HEMOLYTIC UREMIC SYND;
Purpura, Thrombocytopenic | - 377. Thymol
- [2-Isopropyl-5-methyl phenol. A preservative for 24 Hr Urine samples ( HL7V3.0 )] (UMLS (HL7) C1550091) =Intellectual Product ;
=MaterialEntityAdditive;
|
- 328. Thrombocytopenia Due to Immune Destruction
- (UMLS (NCI) C0272286) =Disease or Syndrome
| - 378. Thymolipoma
- [An unusual benign tumor of the thymus found in young to middle-aged adults. Distinctive features include lobules of unremarkable thymic tissue, complete with cortex, medulla and Hasall corpuscles, admixed evenly with mature adipose tissue and bound by thin fibrous capsule. ( NCI )] (UMLS (NCI) C1336744) Thymolipomatous Hamartoma =Neoplastic Process ;
|
- 329. Thrombocytopoiesis
- [formation of blood platelets. ( CSP )] (UMLS (NCI) C0221145) =Organ or Tissue Function ;
=hematopoiesis;
| - 379. thymoma
- [A tumor of the thymus, an organ that is part of the lymphatic system and is located in the chest, behind the breastbone. ( NCI )] (UMLS (NCI) C0040100) =Neoplastic Process =Neoplasm of the Thymus;
Neoplasms, Complex and Mixed |
- 330. Thrombocytosis
- [increased number of platelets in the peripheral blood. ( CSP )] (UMLS (NCI) C0836924) =Disease or Syndrome =Blood Platelet Disorders;
MPD =Essential Thrombocytemia | - 380. Thymopoietin
- [polypeptide hormone secreted by thymic epithelial cells; promotes differentiation of precursor lymphocytes into thymocytes. ( CSP )] (UMLS (NCI) C0040105) =Amino Acid, Peptide, or Protein; Hormone; Immunologic Factor =leukopoietic factor;
|
- 331. thrombohemorrhagic event
- [A process that involves either a blood clot or bleeding, such as a heart attack or stroke. ( NCI )] (UMLS (NCI) C1336741) =Disease or Syndrome ;
| - 381. thymosin
- [polypeptide hormone secreted by thymic epithelial cells; maintains immune system functions and can restore T cell function in thymectomized animals. ( CSP )] (UMLS (CSP) C0040106) =Amino Acid, Peptide, or Protein; Hormone ;
=leukopoietic factor;
|
- 332. thrombolysis
- [The process of breaking up and dissolving blood clots. ( NCI )] (UMLS (CSP) C0520997) =Clinical Attribute
| - 382. Thymosin Beta-15
- [Thymosin Beta-15 (Thymosin-Beta Family) may be an actin-binding protein and positive cell motility factor that opposes the activity of motility suppressor KAI1. Involved in metastasis and prostate cancer, TMSB15 may be a new target for therapy. (from OMIM and NCI) ( NCI )] (UMLS (NCI) C0532005) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 333. thrombomodulin
- [vascular endothelium surface glycoprotein which binds thrombin and accelerates its activation of protein C, thus exerting an anticoagulant and antiinflammatory effect. ( CSP )] (UMLS (CSP) C0145779) =Amino Acid, Peptide, or Protein; Receptor ;
=Blood Coagulation Factor;
| - 383. thymus alymphoplasia
- [ ] (UMLS (CSP) C0599539) =Disease or Syndrome ;
|
- 334. thrombophlebitis
- [(throm-bo-fleh-BY-tis) Inflammation of a vein that occurs when a blood clot forms. ( NCI )] (UMLS (NCI) C0040046) =Disease or Syndrome =phlebitis;
venous thrombosis | - 384. Thymus Cortex
- (UMLS (NCI) C0229948) =Body Part, Organ, or Organ Component
|
- 335. THROMBOPHLEBITIS MIGRANS
- (UMLS (ICD9CM) C0152250) =Disease or Syndrome ;
| - 385. thymus dependent immune system
- [ ] (UMLS (CSP) C0598100) =Body Space or Junction ;
|
- 336. thrombopoietic factor
- [humoral regulator of production of blood platelets. ( CSP )] (UMLS (CSP) C0597581) =Organic Chemical; Biologically Active Substance =hematopoietic growth factor;
| - 386. thymus hormone
- [Humoral factors secreted by the thymus gland. They participate in the development of the lymphoid system and the maturation of the cellular immune response. ( MSH )] (UMLS (CSP) C0040114) =Hormone
|
- 337. THROMBOS HEMORRHOIDS NOS
- [ ] (UMLS (ICD9CM) C0235326) =Disease or Syndrome
| - 387. Thymus Medulla
- (UMLS (NCI) C0229949) =Body Part, Organ, or Organ Component
|
- 338. thrombosis
- [formation, development, or presence of a thrombus. ( CSP )] (UMLS (NCI) C0040053) =Pathologic Function =Embolism and Thrombosis;
blood vessel occlusion =venous thrombosis;
coronary occlusion/thrombosis;
coronary thrombosis;
Purpura, Thrombotic Thrombocytopenic;
Embolism and thrombosis of unspecified site;
venous thrombosis | - 388. THYMUS TRANSPLANTATION
- [transference of the thymus gland between individuals of the same species or between individuals of different species. ( CSP )] (UMLS (ICD9CM) C0194035) =Therapeutic or Preventive Procedure =endocrine transplantation;
lymphatic tissue transplantation |
- 339. Thrombospondin
- [multifunctional glycoprotein secreted by endothelial cells and by alpha granules of platelets following activation by thrombin; interacts with a wide variety of molecules to play a role in platelet aggregation, tumor metastasis, vascular smooth muscle growth, and microorganism adhesion. ( CSP )] (UMLS (NCI) C0076560) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Adhesion Molecule;
Extracellular Matrix Protein | - 389. Thyoglycolate broth
- [A nutritive medium with a reducing agent (sodium thioglycolate) which, due to a chemical reaction, removes oxygen from the broth. ( HL7V3.0 )] (UMLS (HL7) C1553433) =Intellectual Product =MaterialEntityAdditive;
|
- 340. Thrombospondin Type I Domain 2 Protein
- [Encoded by human THSD2 Gene, Thrombospondin Type I Domain 2 Protein contains a furin-like cysteine-rich region and is similar to thrombospondin type 1 domain-containing proteins. Furin-like domains have been found in proteins involved in signal transduction by receptor tyrosine kinases. The function of this protein has not been determined. (NCI) ( NCI )] (UMLS (NCI) C1259459) THSD2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 390. Thyoglycollate broth
- (UMLS (HL7) C1550092) =Biomedical or Dental Material ;
=Additive/Preservative;
|
- 341. thrombosthenin
- [ ] (UMLS (CSP) C0076562) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 391. Thypinone
- (UMLS (NCI) C0699184) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 342. Thromboxane
- [physiologically active compounds found in many organs of the body, formed in vivo from the prostaglandin endoperoxides and causing platelet aggregation, contraction of arteries, and other biological effects; important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. ( CSP )] (UMLS (NCI) C0040061) =Eicosanoid; Biologically Active Substance ;
=eicosanoid;
| - 392. Thyrel Trh
- (UMLS (NCI) C0723741) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 343. thromboxane receptor
- [Cell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems. ( MSH )] (UMLS (CSP) C0076566) =Amino Acid, Peptide, or Protein; Receptor ;
| - 393. Thyreotropin
- [glycoprotein hormone of the anterior pituitary that promotes the growth of, sustains, and stimulates hormonal secretion of the thyroid gland. ( CSP )] (UMLS (NCI) C0040160) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone ;
=neuropeptide;
[HS700] PITUITARY =Glycoprotein Hormones, alpha Subunit |
- 344. through
- [Condition must be true throughout the execution and the service is interrupted (asynchronously) as soon as the condition turns false (asynchronous WHILE loop). The service must be interruptible. ( HL7V3.0 )] (UMLS (HL7) C1550549) =Temporal Concept =ActRelationshipCheckpoint;
| - 394. Thyroarytenoid Muscle
- (UMLS (NCI) C0224183) =Body Part, Organ, or Organ Component
|
- 345. thrush
- [ ] (UMLS (CSP) C0326586) =Bird
| - 395. Thyroepiglottic Ligament
- (UMLS (NCI) C0225514) =Body Part, Organ, or Organ Component
|
- 346. Thumb
- (UMLS (HL7) C0040067) =Body Part, Organ, or Organ Component =Body Part;
| - 396. Thyroepiglottic Muscle
- (UMLS (NCI) C0224182) =Body Part, Organ, or Organ Component
|
- 347. THUMB REATTACHMENT
- [ ] (UMLS (ICD9CM) C0177650) =Therapeutic or Preventive Procedure
| - 397. Thyroglossal Duct
- (UMLS (NCI) C0231104) =Embryonic Structure
|
- 348. Thumbnail
- (UMLS (HL7) C0222002) =Body Part, Organ, or Organ Component =Body Part;
| - 398. Thyroglossal duct/cyst/
- [A cyst in the neck caused by persistence of portions of, or by lack of closure of, the primitive thyroglossal duct. (Dorland, 27th ed)(MSH)] (UMLS (ICPC) C0040124) (Thyroglossal duct/cyst/; KISTE KANAL TIROGLOSOA; Tyreoglossuscyste; Persist ductus thyreoglossus/kyste; KAULAKYSTA/FISTELI; Kyste canal thyreoglosse; persist Ductus thyreoglossus/Zyste; (108); duct. thyreogolss. cysta; Cisti del dotto tireoglosso; DUCTUS/CYSTIS THYREOGLOSSI; Quisto do canal tireoglosso; Conducto/quiste tireogloso; PERSISTENT DUCTUS THYREOGLOSSUS/FISTEL) =Disease or Syndrome =cyst; ENDOCRINE, METABOLIC AND NUTRITIONAL; Diagnosis/Diseases Component;
|
- 349. Thursday
- (UMLS (NCI) C0585028) =Temporal Concept =Days of the week;
| - 399. Thyrohyoid
- (UMLS (NCI) C0224167) =Body Part, Organ, or Organ Component
|
- 350. Thymalfasin
- [A synthetic analogue of thymosin-alpha-1, a 28-amino acid protein derived from the precursor protein prothymosin-alpha. Exhibiting a variety of immunoregulating properties, thymosin-alpha-1 induces differentiation of murine T-cell precursors and human thymocytes and the terminal differentiation of functionally immature cord blood lymphocytes and induces production of IL-2, high affinity IL-2 receptors, and B-cell growth factors by peripheral blood mononuclear cells. T-helper and cytotoxic/suppressor T-cell populations are targets of thymosin activity. Thymosin-alpha-1 has been shown to increase the efficiency of antigen presentation by macrophages and to be an endogenous modulator of alpha-thrombin activity. (NCI04) ( NCI )] (UMLS (NCI) C0076612) =Organic Chemical; Pharmacologic Substance ;
| - 400. Thyrohyoid Ligament
- (UMLS (NCI) C0225534) =Body Part, Organ, or Organ Component
|
home
